Literature DB >> 2899380

On the relationship between incorporation of 32P into phospholipids and binding of beta-adrenoceptor blocking drugs to isolated mast cells.

J Pecivová1, K Drábiková, V Jancinová, R Nosál.   

Abstract

The lipophilic beta-adrenoceptor blocking drugs exaprolol and propranolol significantly decreased the incorporation of 32P into phosphatidylethanolamine, phosphatidylcholine and phosphatidylinositol of isolated rat mast cells. In contrast, the hydrophilic drugs metipranolol, practolol and atenolol increased the incorporation of 32P into phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol. The inhibition of 32P incorporation by lipophilic drugs correlated with the high binding of these drugs to mast cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899380     DOI: 10.1007/bf02142524

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  Simultaneous inhibitions of inositol phospholipid breakdown, arachidonic acid release, and histamine secretion in mast cells by islet-activating protein, pertussis toxin. A possible involvement of the toxin-specific substrate in the Ca2+-mobilizing receptor-mediated biosignaling system.

Authors:  T Nakamura; M Ui
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

2.  Action of calcium channel and beta-adrenergic blocking agents in bilayer lipid membranes.

Authors:  B Shi; H T Tien
Journal:  Biochim Biophys Acta       Date:  1986-07-24

3.  Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazine.

Authors:  A Langslet
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

4.  Stimulation of 32 P i incorporation into phosphatidylinositol and phosphatidyglycerol by catecholamines and -adrenergic receptor blocking agents in rat pineal organ cultures.

Authors:  J Eichberg; H M Shein; M Schwartz; G Hauser
Journal:  J Biol Chem       Date:  1973-05-25       Impact factor: 5.157

5.  Enhanced synthesis de novo of phosphatidylinositol in lymphocytes treated with cationic amphiphilic drugs.

Authors:  D Allan; R H Michell
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

6.  On the interaction of beta-adrenoceptor-blocking drugs with isolated mast cells.

Authors:  R Nosál; J Pecivová; K Drábiková
Journal:  Agents Actions       Date:  1985-09

7.  Evidence for intracellular histamine liberation in isolated rat mast cells.

Authors:  R Nosál; J Pecivova; K Drábiková
Journal:  Agents Actions       Date:  1982-12

8.  Impaired function of TXA2 and/or calcium in the platelets from SHRSP at hypertensive ages.

Authors:  T Tomita; K Umegaki; K Nakamura; E Hayashi
Journal:  Thromb Res       Date:  1984-07-15       Impact factor: 3.944

  8 in total
  7 in total

1.  Membrane perturbing activity of beta-adrenoceptor blocking drugs in isolated rat mast cells.

Authors:  R Nosál; K Drábiková; J Pecivová; K Ondrias
Journal:  Agents Actions       Date:  1989-04

2.  Atenolol, exaprolol and mast cell membranes.

Authors:  J Pecivová; K Drábiková; V Jancinová; M Petríková; R Nosál
Journal:  Agents Actions       Date:  1991-05

3.  The effect of beta-adrenoceptor blocking drugs on histamine liberation, prostaglandin synthesis and phospholipid turnover in isolated mast cells stimulated with concanavalin A.

Authors:  K Drábiková; J Pecivová; M Petríková; V Jancinová; R Nosál
Journal:  Agents Actions       Date:  1990-04

4.  Histamine liberation as a result of nonreceptor interaction.

Authors:  R Nosál; K Drábiková; J Pecivová; J Jakubovský
Journal:  Agents Actions       Date:  1990-04

5.  Effect of beta-adrenoceptor blocking drugs on 32P incorporation into and arachidonic acid liberation from phospholipids in stimulated rat mast cells.

Authors:  J Pecivová; K Drábiková; R Nosál
Journal:  Agents Actions       Date:  1989-04

6.  Effect of chloroquine on mast cell membranes.

Authors:  J Pecivová; K Drábiková; R Nosál
Journal:  Agents Actions       Date:  1994-06

7.  Histamine liberation and membrane fluidisation of mast cells exposed to the beta-adrenoceptor blocking drug propranolol.

Authors:  R Nosál; K Ondrias; J Pecivová; K Drábiková
Journal:  Agents Actions       Date:  1988-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.